Dr. Erkut Borazanci, MD
Claim this profileHonor Health Research Institute
Studies Pancreatic Cancer
Studies Cancer
14 reported clinical trials
23 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
CA19-9 positive
2Cancer
Stage IV
Stage III
CA19-9 positive
Affiliated Hospitals
Clinical Trials Erkut Borazanci, MD is currently running
Botensilimab + Chemotherapy
for Pancreatic Cancer
This trial is testing whether adding a new drug, botensilimab, to standard chemotherapy can better treat patients with advanced pancreatic cancer. The study will ensure the new drug is safe and determine the right dose. It will also compare the effectiveness of the new combination treatment to chemotherapy alone.
Recruiting1 award Phase 2
ONC-392 + Pembrolizumab
for Non-Small Cell Lung Cancer
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Recruiting1 award Phase 1 & 212 criteria
More about Erkut Borazanci, MD
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Erkut Borazanci, MD has experience with
- Gemcitabine
- AOH1996
- Cisplatin
- Hydroxychloroquine
- Paclitaxel Protein Bound
- ONC-392
Breakdown of trials Erkut Borazanci, MD has run
Pancreatic Cancer
Cancer
Solid Tumors
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erkut Borazanci, MD specialize in?
Erkut Borazanci, MD focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Erkut Borazanci, MD currently recruiting for clinical trials?
Yes, Erkut Borazanci, MD is currently recruiting for 6 clinical trials in Scottsdale Arizona. If you're interested in participating, you should apply.
Are there any treatments that Erkut Borazanci, MD has studied deeply?
Yes, Erkut Borazanci, MD has studied treatments such as Gemcitabine, AOH1996, Cisplatin.
What is the best way to schedule an appointment with Erkut Borazanci, MD?
Apply for one of the trials that Erkut Borazanci, MD is conducting.
What is the office address of Erkut Borazanci, MD?
The office of Erkut Borazanci, MD is located at: Honor Health Research Institute, Scottsdale, Arizona 85258 United States. This is the address for their practice at the Honor Health Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.